EQT to exit Fertin Pharma to Philip Morris International for DKK5.1bn EV after growing EBITDA by almost 50%

European private equity major EQT Private Equity has agreed to sell Fertin Pharma to Philip Morris International for an enterprise value of DKK5.1bn (€685.9m) after growing its EBITDA by almost 50%.

The post EQT to exit Fertin Pharma to Philip Morris International for DKK5.1bn EV after growing EBITDA by almost 50% first appeared on AltAssets Private Equity News.